These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1187555)

  • 1. [Drug therapy of minimal brain dysfunction syndrome (clinical study using Captagon)].
    Mangold B
    Prax Kinderpsychol Kinderpsychiatr; 1975 Jul; 24(5):185-90. PubMed ID: 1187555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical picture, diagnosis and treatment possibilities of minimal brain dysfunction].
    Peters H; Vogt HJ
    Offentl Gesundheitswes; 1988; 50(8-9):480-4. PubMed ID: 2972964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of attention deficit disorders in adulthood using psychostimulants and low-dose neuroleptics--a critical case report].
    Schmidt LG; Schlünder M; Reischies FM
    Psychiatr Prax; 1988 Mar; 15(2):62-5. PubMed ID: 2898788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The minimal brain dysfunction syndrome].
    Verret S
    Vie Med Can Fr; 1973 Jul; 2(7):649-55. PubMed ID: 4760948
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenetylline: therapeutic use, misuse and/or abuse.
    Kristen G; Schaefer A; von Schlichtegroll A
    Drug Alcohol Depend; 1986 Jun; 17(2-3):259-71. PubMed ID: 3743408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperactivity and attention deficit with amphetamine. Experience with five adult prisoners].
    Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2002-5. PubMed ID: 8766640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amphetamine in the therapy of hyperactivity in children].
    Scholander T
    Lakartidningen; 1982 Dec; 79(50):4759-61. PubMed ID: 7154786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Minimal cerebral dysfunction. Apropos of the treatment of 90 cases].
    Vildoso de Palacios E
    Rev Neuropsiquiatr; 1971 Dec; 34(4):301-8. PubMed ID: 5164564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urine levels of fenethylline and amphetamine after administration of Captagon].
    Iffland R
    Arch Kriminol; 1982; 169(3-4):81-8. PubMed ID: 7082126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal brain dysfunctions in children.
    Peters JE
    Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
    [No Abstract]   [Full Text] [Related]  

  • 14. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of early-childhood minimal brain damage].
    Zueblin W
    Bull Schweiz Akad Med Wiss; 1976 Jul; 32(1-3):141-6. PubMed ID: 990576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperkinetic syndrome in childhood and adolescence. Diagnosis and therapy].
    Schulz E; Remschmidt H
    Med Monatsschr Pharm; 1991 May; 14(5):137-48. PubMed ID: 1857319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Minimal brain dysfunction syndrome in children].
    Karkowski M
    Wiad Lek; 1984 Oct; 37(20):1605-10. PubMed ID: 6396962
    [No Abstract]   [Full Text] [Related]  

  • 18. The hyperactive child.
    Muiva PM
    East Afr Med J; 1979 May; 56(5):237-40. PubMed ID: 467294
    [No Abstract]   [Full Text] [Related]  

  • 19. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: a preliminary report.
    Donnelly M; Rapoport JL; Ismond DR
    Psychopharmacol Bull; 1986; 22(1):152-4. PubMed ID: 3523573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.